Compare JBTM & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBTM | HIMS |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | 11500 | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.0B |
| IPO Year | N/A | 2019 |
| Metric | JBTM | HIMS |
|---|---|---|
| Price | $131.69 | $23.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 15 |
| Target Price | ★ $180.00 | $30.46 |
| AVG Volume (30 Days) | 512.3K | ★ 20.4M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | $8.10 | $19.82 |
| Revenue Next Year | $4.68 | $19.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $111.97 | $13.74 |
| 52 Week High | $170.19 | $70.43 |
| Indicator | JBTM | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 45.16 |
| Support Level | $122.13 | $18.62 |
| Resistance Level | $138.79 | $31.12 |
| Average True Range (ATR) | 5.32 | 1.60 |
| MACD | 0.42 | -0.53 |
| Stochastic Oscillator | 48.26 | 21.68 |
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.